Amytrx Therapeutics
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Amytrx Therapeutics Information
Geographic Data
Address: 102 Woodmont Boulevard
City: Nashville
State: TN
Zip: 37205
Country: US
Financial Info
Stage:
series a
Raised Last:
$18M
Raised Total:$18M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies for patients with chronic inflammatory diseases. The company&s;s AMTX-100 is bioengineered using human protein sequences that modulate the immune system by a natural process. Amytrx Therapeutics was founded in 2014 by Matthew A. Gonda and is based in Nashville, Tennessee.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Series A | $18M | 9/2020 | Series A | $11M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
